Mechanistic studies demonstrated that IGFL2‐AS1 upregulated the CA9 level by affecting the degradation pathway of HIF‐1α, which elucidates its pro‐proliferative effect in CRC. This evidence concerns the gene IGFL2 and colorectal carcinoma.